SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

THIRTEENTH MANDATORY REDEMPTION

29 Dec 2025 15:18

RNS Number : 0301N
JPEL Private Equity Limited
29 December 2025
 

JPEL Private Equity Limited

60, Fourth Floor

Plaza House

Admiral Park

St Peter Port, Guernsey, GY1 4BF

www.jpelonline.com

 

 

THIRTEENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE

 

 

 

· JPEL WILL RETURN $6 MILLION TO SHAREHOLDERS

 

· REDEMPTION DATE 13 JANUARY 2026

 

· REDEMPTION REPRESENTS 21% OF US$ EQUITY SHAREHOLDER NET ASSET VALUE AT 30 SEPTEMBER 2025

 

· REDEMPTION REPRESENTS APPROXIMATELY 24% OF JPEL's MARKET CAPITALIZATION AT 23 DeCEMBER 2025

 

 

* * *

 

GUERNSEY, 29 DECEMBER 2025

 

 

The Company is pleased to announce its thirteenth Mandatory Redemption to US$ Equity Shareholders. The amount of the redemption will be $6 million or 21% of NAV at 30 September 2025 (approximately 24% of JPEL's market capitalization at 23 December 2025).

 

The $6 million capital return (the equivalent of approximately 4.5 million US$ Equity Shares) will be by way of a pro rata compulsory redemption of US$ Equity Shares at a price equal to the prevailing NAV per US$ Equity Share of $1.32 as at 30 September 2025 (being the most recent NAV per US$ Equity Share available as of the date of this announcement) for US$ Equity Shareholders on the register of members as at close of business on 13 January 2026 (the "Record Date"). Unless circumstances require otherwise, this NAV will form the NAV per US$ Equity Share as of the date of redemption.

 

Payments of redemption proceeds are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) on or around 27 January 2026. Any share certificates for the balance of holdings of shares will also be despatched to shareholders on or around 27 January 2026.

 

The Company currently has 21,648,389 US$ Equity Shares in issue. All of the US$ Equity Shares redeemed on the redemption date will be cancelled and any fractions of shares will be rounded down to the nearest whole share.

 

The US$ Equity Shares will be disabled in CREST on the Record Date and the existing ISIN number GG00BS82YQ75 (the "Old ISIN") will expire. A new ISIN number GG00BVPBWF31 (the "New ISIN") in respect of the remaining US$ Equity Shares which have not been redeemed will be enabled and available for transactions on 14 January 2026 (the "Ex-date"). For the period up to and including the Record date, US$ Equity Shares will be traded under the Old ISIN and as such, a purchaser of such shares may have a market claim for the redemption proceeds following the activation of the New ISIN. CREST will automatically transfer any open transactions as at the redemption date to the New ISIN.

 

Inclusive of this Mandatory Redemption, JPEL will have returned $537.6 million to US$ Equity Shareholders, or approximately 112% and 141% of the Company's 31 October 2016 NAV and market capitalization. Please note that the prevailing NAV at the time of the Company's first mandatory redemption was 31 October 2016.

 

BOARD SUCCESSSION

 

As previously announced on 2 December 2025, a process is underway to refresh Board configuration. In order to ensure an orderly Board succession plan, this process is anticipated to be completed within six months. The Board remains mindful of its fiduciary duties to all shareholders including its commitment to focus on minimising costs appropriately.

 

As a first stage of this orderly transition, Sean Hurst resigned as a director of the Company on 2 December 2025. Tony Dalwood was appointed Chair to oversee the succession plan. Trina Le Noury remains Chair of the Audit committee.

 

The appointment of additional Non-Executive Directors is progressed and, subject to completion of the relevant regulatory approvals, at least one new Director will join the Board shortly. A further update will be provided in due course.

 

 

DIRECTOR'S INTERESTS

 

As of 29 December 2025, Tony Dalwood owned 8,185 US$ Equity Shares. As a result of the Mandatory Redemption described above, Tony Dalwood is expected, immediately following the redemption date, to hold approximately 6,467 US$ Equity Shares.

 

 

* * *

 

 

LEI Number: 5493005M6GBE3DNJZ894

 

 

 

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CASTLBATMTMTBRA
Date   Source Headline
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.